Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
James Darecca currently holds 54,444 shares of TherapeuticsMD, Inc. (TXMD), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James Darecca has been a net seller of TXMD stock. They have purchased $0 and sold $81.2K worth of shares.
James Darecca's most recent insider trade was on May 15, 2026, when they sold 29,312 shares at $0.00 per share.
James Darecca serves as Executive at TherapeuticsMD, Inc. (TXMD). They have executed 46 insider transactions totaling $81.2K over their tenure at the company.
James Darecca holds the position of Executive at TherapeuticsMD, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 12 years and currently hold a stake valued at $0.
James Darecca has shown a selling trading pattern, with $0 in total purchases and $81.2K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by James Darecca was on Mar 2, 2020, when they purchased $700.0K worth of AGN shares. This transaction involved 3,611 shares at $193.84 per share.
James Darecca currently owns 54,444 shares of TherapeuticsMD, Inc. (TXMD), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of James Darecca's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. James Darecca has 46 Form 4 filings on record as an insider at TherapeuticsMD, Inc..
Set alerts for James Darecca and 40,000+ other insiders.